Actively Recruiting
Study on Changes in Pain Sensitivity During Gender Affirming Hormone Therapy for Transgender Adults
Led by Medical University of Vienna · Updated on 2025-08-29
40
Participants Needed
1
Research Sites
12 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are exploring how pain perception differs between women and men, focusing on the role of sex hormones. They suspect that typical female hormone levels may contribute to a lower pain threshold compared to men. This study aims to track changes in pain and sensory thresholds over time in transgender individuals starting hormone therapy to align their physical traits with their gender identity. Participants include transgender men and women undergoing gender-affirming hormone therapy, receiving hormones typical of the opposite sex. The study involves four measurement points before therapy starts, 3-4 weeks after, then at 3 months and 6 months. Each visit includes blood sampling to assess hormone levels and quantitative sensory testing QST to measure various pain and sensory thresholds. Participants will complete a mental health questionnaire PHQ-9 at the beginning and end of the 6-month study. Researchers will monitor thresholds such as cold and warm detection, pain thresholds, and skin temperature. The study observes changes without affecting participant treatment, aiming for a total commitment of 6 months with assessments spaced as scheduled.
CONDITIONS
Brief Title
Perception of Pain During Gender Affirming Hormone Therapy
Research Team
A
Aylin Bilir, Dr. med. univ.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here